FARON PHARMACEUTICALS OY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 197.5 GBX | +27.42% |
|
+31.67% | -35.25% |
| May. 03 | Kelso raises stake in NCC; Transense joins project | AN |
| Apr. 30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FARON PHARMACEUTICALS OY | Bio Therapeutic Drugs | +27.42% | +31.67% | -35.25% | -35.25% | +172.41% | 178M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- FARN Stock
- Charts Faron Pharmaceuticals Oy
- Comparison Chart